AIGH Capital Management as of March 31, 2024
Portfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 43 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 28.5 | $95M | 1.0M | 94.89 | |
| Micron Technology Call Option (MU) | 9.2 | $31M | 260k | 117.89 | |
| Scpharmaceuticals (SCPH) | 5.1 | $17M | 3.4M | 5.02 | |
| Electrovaya Com New (ELVA) | 4.5 | $15M | 4.1M | 3.65 | |
| Ouster Com New (OUST) | 4.4 | $15M | 1.9M | 7.94 | |
| Cellectar Biosciences Com New (CLRB) | 3.3 | $11M | 2.8M | 3.98 | |
| Delcath Sys Com New (DCTH) | 3.3 | $11M | 2.4M | 4.63 | |
| Myomo Com New (MYO) | 2.7 | $9.2M | 2.8M | 3.27 | |
| Tela Bio (TELA) | 2.4 | $8.0M | 1.4M | 5.67 | |
| Humacyte (HUMA) | 2.0 | $6.7M | 2.2M | 3.11 | |
| Beyond Air (XAIR) | 1.9 | $6.5M | 3.7M | 1.74 | |
| Coya Therapeutics Common Stock (COYA) | 1.9 | $6.4M | 649k | 9.92 | |
| Fennec Pharmaceuticals (FENC) | 1.9 | $6.3M | 570k | 11.12 | |
| Ideal Pwr Com New (IPWR) | 1.9 | $6.2M | 700k | 8.90 | |
| Eagle Pharmaceuticals (EGRX) | 1.9 | $6.2M | 1.2M | 5.24 | |
| Theratechnologies Com New (THTX) | 1.8 | $6.1M | 3.7M | 1.63 | |
| Alimera Sciences Com New | 1.8 | $5.9M | 1.5M | 3.90 | |
| Onespan (OSPN) | 1.7 | $5.8M | 500k | 11.63 | |
| Profound Med Corp Com New (PROF) | 1.7 | $5.5M | 647k | 8.53 | |
| Infinera (INFN) | 1.6 | $5.4M | 889k | 6.03 | |
| Intellicheck Com New (IDN) | 1.6 | $5.3M | 1.5M | 3.48 | |
| Lightpath Technologies Com Cl A (LPTH) | 1.5 | $4.9M | 3.5M | 1.38 | |
| Bk Technologies Corporation Com New (BKTI) | 1.4 | $4.8M | 331k | 14.60 | |
| Immix Biopharma (IMMX) | 1.4 | $4.8M | 1.6M | 3.07 | |
| Biodesix (BDSX) | 1.4 | $4.7M | 3.3M | 1.43 | |
| Red Cat Hldgs (RCAT) | 1.1 | $3.8M | 5.0M | 0.77 | |
| Aprea Therapeutics Com New (APRE) | 1.0 | $3.5M | 539k | 6.45 | |
| Cognition Therapeutics (CGTX) | 1.0 | $3.5M | 1.9M | 1.82 | |
| In8bio (INAB) | 1.0 | $3.4M | 2.9M | 1.18 | |
| Polypid (PYPD) | 0.7 | $2.4M | 479k | 5.00 | |
| Adverum Biotechnologies Com New (ADVM) | 0.7 | $2.3M | 163k | 14.14 | |
| Cybin Ord (CYBN) | 0.6 | $1.9M | 4.7M | 0.40 | |
| Acasti Pharma Cl A (ACST) | 0.5 | $1.7M | 497k | 3.45 | |
| Kiora Pharmaceuticals Com New | 0.5 | $1.6M | 2.3M | 0.71 | |
| Elutia Cl A Com (ELUT) | 0.4 | $1.4M | 437k | 3.15 | |
| Brainsway Sponsored Ads (BWAY) | 0.4 | $1.3M | 243k | 5.29 | |
| Franklin Wireless Corporation (FKWL) | 0.3 | $1.2M | 390k | 2.99 | |
| Biofrontera Com New (BFRI) | 0.2 | $766k | 501k | 1.53 | |
| Kwesst Micro Systems Com New (KWE) | 0.2 | $632k | 502k | 1.26 | |
| Evoke Pharma Com New (EVOK) | 0.2 | $516k | 847k | 0.61 | |
| Vaccinex (VCNX) | 0.1 | $433k | 58k | 7.41 | |
| Kwesst Micro Systems *w Exp 12/09/202 (KWESW) | 0.0 | $60k | 599k | 0.10 | |
| Saverone 2014 *w Exp 06/02/202 (SVREW) | 0.0 | $51k | 568k | 0.09 |
